JSP 507
Pill imprint JSP 507 has been identified as Aspirin, butalbital, caffeine and codeine 325 mg / 50 mg / 40 mg / 30 mg.
Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy.
Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg has a moderate potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
See also related documents.
Aspirin, butalbital, caffeine and codeine Images
- Imprint:
-
JSP
507 - Strength:
- 325 mg / 50 mg / 40 mg / 30 mg
- Color:
- Blue & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 3 - Moderate abuse potential
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1312
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63874-0219 | Altura Pharmaceuticals Inc (repackager) |
| 58016-0322 | Southwood Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Aspirin, Butalbital, Caffeine and Codeine resources
- Aspirin/Butalbital/Caffeine/Codeine (Wolters Kluwer)
- aspirin, butalbital, caffeine, and codeine (Cerner Multum)
- Butalbital,Aspirin,Caffeine,Codeine (FDA)
- Butalbital/Aspirin/Caffeine/Codeine Phosphate (Wolters Kluwer)


